Skip to main content

UBS Group AG

Position in ABOS — Acumen Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in ABOS

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$87,663
+$42,169 QoQ
Shares Held
37,146
+72.3% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 84 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 99.98384752059441.ToString("F0")% Shared 0.ToString("F0")% None 0.016152479405588758.ToString("F0")%

Common Shares in ABOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. ABOS ranks #363 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABOS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $87,663 37,146
2025-12-31 $45,494 21,562
2025-09-30 $52,737 30,841
2025-06-30 $109,528 94,422
2025-03-31 $135,315 123,015
2024-12-31 $243,365 141,492
2024-09-30 $56,421 22,751
2024-06-30 $30,942 12,786
2024-03-31 $26,903 6,643
2023-12-31 $30 8
2023-09-30 $415 100
2023-03-31 $12,735 3,137
2022-09-30 $26,950 2,687
2022-03-31 $20,507 5,245
2021-12-31 $5,793 857
2021-09-30 $9,064 610